SHARE
 
Michael R. Lucey, MD close
B_scpuW6mWg
Michael R. Lucey, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Michael R. Lucey, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Lucey's practice is devoted to advanced hepatology (e.g., diseases of the liver) and liver transplantation.

Specialties

Gastroenterology and Hepatology

Transplant Medicine

Alcoholic Liver Disease

Barrett's Esophagus

Colonoscopy

Esophagogastroduodenoscopy with Control of Bleeding

Hepatitis

Hepatology

Liver Biopsy

Liver Disease

Liver Transplant

Liver Transplant Medicine

Clinics

Digestive Health Center
(608) 890-5000 | (855) 342-9900 | Map
University Hospital
(608) 262-5420 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Gastroenterology
Transplant Hepatology
Fellowship Kings College Hospital, London, England
University of Michigan Medical Center, Ann Arbor, MI
St. Bartholomew's Hospital, London, England
Residency St. Vincent's University Hospital, Dublin, Ireland
Federated Dublin Voluntary Hospitals, Dublin, Ireland
Internship Meath Hospital, Dublin, Ireland
Medical School University of Dublin, Ireland

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Lucey’s research interests include alcoholic liver disease and liver transplantation.


Publications

Read Dr. Lucey’s articles on PubMed


PubMed Articles
Daniel KE Lucey MR Editorial: moderate alcoholic hepatitis-hiding in plain sight. Aliment Pharmacol Ther . 2019 Sep;50(5):608-609
[PubMed ID: 31414539]
Lee BP Samur S Dalgic OO Bethea ED Lucey MR Weinberg E Hsu C Rinella ME Im GY Fix OK Therapondos G Han H Victor DW Voigt MD Eswaran S Terrault NA Chhatwal J Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis. Gastroenterology . 2019 Aug;157(2):472-480.e5
[PubMed ID: 30998988]
Poordad F Sedghi S Pockros PJ Ravendhran N Reindollar R Lucey MR Epstein M Bank L Bernstein D Trinh R Krishnan P Polepally AR Unnebrink K Martinez M Nelson DR Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. J Viral Hepat . 2019 Aug;26(8):1027-1030
[PubMed ID: 30980576]
Crabb DW Im GY Szabo G Mellinger JL Lucey MR Diagnosis and Treatment of Alcohol-Related Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology . 2019 Jul 17;
[PubMed ID: 31314133]
Lucey MR Im GY Mellinger JL Szabo G Crabb DW Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Related Liver Disease. Liver Transpl . 2019 Jul 12;
[PubMed ID: 31299131]
Lee BP Vittinghoff E Hsu C Han H Therapondos G Fix OK Victor DW Dronamraju D Im GY Voigt MD Rice JP Lucey MR Eswaran S Chen PH Li Z Maddur H Terrault NA Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score. Hepatology . 2019 Apr;69(4):1477-1487
[PubMed ID: 30561766]
Sussman NL Lucey MR Alcohol and Alcoholic Liver Disease. Clin Liver Dis . 2019 Feb;23(1):xiii-xiv
[PubMed ID: 30454837]
Lucey MR Alcohol-Associated Cirrhosis. Clin Liver Dis . 2019 Feb;23(1):115-126
[PubMed ID: 30454826]
Im GY Cameron AM Lucey MR Liver transplantation for alcoholic hepatitis. J Hepatol . 2019 Feb;70(2):328-334
[PubMed ID: 30658734]
Arab JP Roblero JP Altamirano J Bessone F Chaves Araujo R Higuera-De la Tijera F Restrepo JC Torre A Urzua A Simonetto DA Abraldes JG Méndez-Sánchez N Contreras F Lucey MR Shah VH Cortez-Pinto H Bataller R Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol . 2019 May - Jun;18(3):518-535
[PubMed ID: 31053546]
Agarwal PD Lucey MR Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward. Am J Gastroenterol . 2018 Oct;113(10):1435-1436
[PubMed ID: 30291316]
Lee BP Mehta N Platt L Gurakar A Rice JP Lucey MR Im GY Therapondos G Han H Victor DW Fix OK Dinges L Dronamraju D Hsu C Voigt MD Rinella ME Maddur H Eswaran S Hause J Foley D Ghobrial RM Dodge JL Li Z Terrault NA Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology . 2018 Aug;155(2):422-430.e1
[PubMed ID: 29655837]
Phillips PK Caldis MW Hristov AD Lee AS Lucey MR Indications for and outcomes of liver transplantation in patients with alcohol-associated liver disease. Minerva Gastroenterol Dietol . 2018 Jun;64(2):126-137
[PubMed ID: 29243894]
Mathurin P Lucey MR Alcohol, liver disease, and transplantation: shifting attitudes and new understanding leads to changes in practice. Curr Opin Organ Transplant . 2018 Apr;23(2):175-179
[PubMed ID: 29394165]
Beresford TP Lucey MR Towards Standardizing the Alcoholism Evaluation Of Potential Liver Transplant Recipients. Alcohol Alcohol . 2018 Mar 1;53(2):135-144
[PubMed ID: 29211831]
Jorgenson MR Descourouez JL Leverson GE McCreary EK Lucey MR Smith JA Redfield RR High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients. Ann Pharmacother . 2018 Jan;52(1):5-10
[PubMed ID: 28844151]
Lucey MR Redefining Successful Treatment of Severe Alcoholic Hepatitis. Hepatology . 2017 Dec;66(6):1722-1723
[PubMed ID: 28741287]
Eccleston JL Lucey MR Substance use disorders before and after liver transplantation. Clin Liver Dis (Hoboken) . 2017 Oct;10(4):100-102
[PubMed ID: 31186896]
Agarwal PD Phillips P Hillman L Lucey MR Lee F Mezrich JD Said A Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival. J Clin Gastroenterol . 2017 Oct;51(9):845-849
[PubMed ID: 28877082]
Lucey MR Impact of behaviors (smoking, treatment adherence, exercise, alcohol) on allograft function and outcomes. Liver Transpl . 2017 Oct;23(S1):S89-S91
[PubMed ID: 28846181]